Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Novel antiinfective agents disclosed in recent patent literature

June 1, 2006

Agents with potential for the treatment of metabolic disorders described in recent patents

May 31, 2006

Recent patents describe new anticoagulants

May 31, 2006

Novel alpha 1a/1d adrenoreceptor antagonists claimed for BPH treatment

May 31, 2006

Sphingosine 1-phosphate S1P1 receptor agonists emerge from Merck R&D

May 31, 2006

Recent patents cover therapeutic agents for neurological disorders

May 30, 2006

Novel agents for treating endocrine-related disorders disclosed in recent patent literature

May 30, 2006

Recent patents describe new analgesic agents

May 30, 2006

New treatment options for inflammatory disorders disclosed

May 29, 2006

Recent patents describe novel agents for anxiety, depression, psychosis, etc.

May 29, 2006

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...